1. Home
  2. GMRE vs TKNO Comparison

GMRE vs TKNO Comparison

Compare GMRE & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMRE
  • TKNO
  • Stock Information
  • Founded
  • GMRE 2011
  • TKNO 1996
  • Country
  • GMRE United States
  • TKNO United States
  • Employees
  • GMRE N/A
  • TKNO N/A
  • Industry
  • GMRE Real Estate Investment Trusts
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • GMRE Real Estate
  • TKNO Health Care
  • Exchange
  • GMRE Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • GMRE 527.1M
  • TKNO 430.2M
  • IPO Year
  • GMRE N/A
  • TKNO 2021
  • Fundamental
  • Price
  • GMRE $8.75
  • TKNO $5.21
  • Analyst Decision
  • GMRE Strong Buy
  • TKNO Buy
  • Analyst Count
  • GMRE 3
  • TKNO 1
  • Target Price
  • GMRE $10.88
  • TKNO $5.00
  • AVG Volume (30 Days)
  • GMRE 480.4K
  • TKNO 531.5K
  • Earning Date
  • GMRE 05-06-2025
  • TKNO 03-04-2025
  • Dividend Yield
  • GMRE 9.64%
  • TKNO N/A
  • EPS Growth
  • GMRE N/A
  • TKNO N/A
  • EPS
  • GMRE 0.01
  • TKNO N/A
  • Revenue
  • GMRE $138,760,000.00
  • TKNO $37,745,000.00
  • Revenue This Year
  • GMRE $6.45
  • TKNO $12.70
  • Revenue Next Year
  • GMRE $3.11
  • TKNO $19.79
  • P/E Ratio
  • GMRE $708.59
  • TKNO N/A
  • Revenue Growth
  • GMRE N/A
  • TKNO 2.89
  • 52 Week Low
  • GMRE $7.33
  • TKNO $1.16
  • 52 Week High
  • GMRE $10.46
  • TKNO $10.37
  • Technical
  • Relative Strength Index (RSI)
  • GMRE 56.87
  • TKNO 36.27
  • Support Level
  • GMRE $8.31
  • TKNO $5.22
  • Resistance Level
  • GMRE $8.81
  • TKNO $5.69
  • Average True Range (ATR)
  • GMRE 0.20
  • TKNO 0.48
  • MACD
  • GMRE -0.03
  • TKNO 0.06
  • Stochastic Oscillator
  • GMRE 59.06
  • TKNO 10.56

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Share on Social Networks: